Amfepramone

Tenuate

25 MG TabletCanadaCancelledAuthorised 31 Dec 1994

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

TenuateUnited States · 25MG, 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · MPP PharmaSame brand
TenuateUnited States · 75MG · tablet, extended release · Sanofi Aventis USSame brand
Tenuate DospanUnited States · 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet, extended release · Ani PharmsSame brand
REGENON 25 mgRomania · 25mg · caps. moi · Temmler Pharma GMBHSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Amfepramone

Tenuate

25 MG TabletCanadaCancelledAuthorised 31 Dec 1994

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Amfepramone
Strength: 25 MG
Dosage form: Tablet
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1994
Registration: DIN 02047675
Marketing authorisation holder: Sanofi-Aventis Canada INC
ATC code: A08AA03
Group: Alimentary tract and metabolism
Supply: CONTROLLED DRUGS (CDSA IV)

Cancelled